MedTrace Logo

A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces

NCT01093833 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-05-06

No results posted yet for this study

Summary

The purpose of this study is to compare two continuous glucose sensors, one placed subcutaneous (under the skin) and one placed intradermal (in the skin) over 12-14 hours.

Conditions

Interventions

DEVICE

BD Continuous glucose monitor (BD CGM)

Continuous glucose monitoring for 12-14 hours

DEVICE

YSI Glucose Analyzer

Continuous glucose monitoring for 12-14 hours

DEVICE

Medtronic Guardian CGM

Continuous glucose monitoring for 12-14 hours

Sponsors & Collaborators

  • Becton, Dickinson and Company

    lead INDUSTRY

Principal Investigators

  • Morrow Linda, MD · Profil Insitute for Clinical Research

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01093833 on ClinicalTrials.gov